• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类肝细胞癌中清除酶活性降低,但肝转移灶中未降低。

Decreased activity of scavenger enzymes in human hepatocellular carcinoma, but not in liver metastases.

作者信息

Casaril M, Corso F, Bassi A, Capra F, Gabrielli G B, Stanzial A M, Nicoli N, Corrocher R

机构信息

Istituto di Patologia Medica-Cattedra di Medicina Interna, University of Verona, Italy.

出版信息

Int J Clin Lab Res. 1994;24(2):94-7. doi: 10.1007/BF02593907.

DOI:10.1007/BF02593907
PMID:7919435
Abstract

To investigate the role of oxygen free radicals in hepatocellular carcinoma we assayed tissue scavenger enzymes (superoxide dismutase and selenium-dependent glutathione peroxidase) in liver homogenate, plasma concentrations of vitamins A and E and the serum selenium level from 19 control patients, 23 cases of hepatocellular carcinoma and 18 cases of metastases to liver from different carcinomas. In hepatocellular carcinoma tissue the enzyme activities were all significantly lower than in control liver and in metastases-bearing liver; the enzyme activities of the latter tissues were not different from control liver. In contrast, normal liver adjacent to the hepatocellular carcinoma had decreased activity of superoxide dismutase. Serum selenium concentrations were significantly decreased in patients with hepatocellular carcinoma and those with liver metastases, while vitamin A was significantly decreased only in the former. These findings suggest that hepatocellular carcinoma develops in liver with severe impairment of cellular antioxidant systems, since, in patients with liver metastases from different cancers, despite low selenium concentrations, cellular scavenger enzymes have normal activities.

摘要

为了研究氧自由基在肝细胞癌中的作用,我们检测了19例对照患者、23例肝细胞癌患者以及18例来自不同癌症的肝转移患者肝脏匀浆中的组织清除酶(超氧化物歧化酶和硒依赖性谷胱甘肽过氧化物酶)、血浆维生素A和E浓度以及血清硒水平。在肝细胞癌组织中,这些酶的活性均显著低于对照肝脏和有转移灶的肝脏;后两者组织的酶活性与对照肝脏无差异。相比之下,肝细胞癌旁的正常肝脏中超氧化物歧化酶活性降低。肝细胞癌患者和肝转移患者的血清硒浓度显著降低,而仅前者的维生素A显著降低。这些发现表明,肝细胞癌是在细胞抗氧化系统严重受损的肝脏中发生的,因为在来自不同癌症的肝转移患者中,尽管硒浓度较低,但细胞清除酶的活性正常。

相似文献

1
Decreased activity of scavenger enzymes in human hepatocellular carcinoma, but not in liver metastases.人类肝细胞癌中清除酶活性降低,但肝转移灶中未降低。
Int J Clin Lab Res. 1994;24(2):94-7. doi: 10.1007/BF02593907.
2
[Preliminary study on cellular status of selenium and oxidative stress in human hepatocellular carcinoma and normal liver].[人肝细胞癌与正常肝脏中硒及氧化应激细胞状态的初步研究]
Wei Sheng Yan Jiu. 2004 Sep;33(5):543-6.
3
Decreased activity of liver glutathione peroxidase in human hepatocellular carcinoma.人类肝细胞癌中肝脏谷胱甘肽过氧化物酶活性降低。
Eur J Cancer Clin Oncol. 1985 Aug;21(8):941-4. doi: 10.1016/0277-5379(85)90112-9.
4
Reduction of liver glutathione peroxidase activity and deficiency of serum selenium in patients with hepatocellular carcinoma.肝细胞癌患者肝脏谷胱甘肽过氧化物酶活性降低及血清硒缺乏
Tumori. 1986 Dec 31;72(6):617-9. doi: 10.1177/030089168607200613.
5
Evaluation of redox statuses in patients with hepatitis B virus-associated hepatocellular carcinoma.乙型肝炎病毒相关肝细胞癌患者氧化还原状态的评估。
Ann Clin Biochem. 2009 Sep;46(Pt 5):394-400. doi: 10.1258/acb.2009.009029. Epub 2009 Jul 29.
6
[Changes in blood selenium level and glutathione peroxidase activity and their clinical significance in primary liver cancer and benign liver diseases].[原发性肝癌及良性肝病患者血硒水平与谷胱甘肽过氧化物酶活性的变化及其临床意义]
Zhonghua Nei Ke Za Zhi. 1988 Oct;27(10):612-4, 652.
7
Genetic polymorphisms in antioxidant enzymes modulate hepatic iron accumulation and hepatocellular carcinoma development in patients with alcohol-induced cirrhosis.抗氧化酶的基因多态性调节酒精性肝硬化患者的肝脏铁蓄积和肝细胞癌发生。
Cancer Res. 2006 Mar 1;66(5):2844-52. doi: 10.1158/0008-5472.CAN-05-2566.
8
[Effect of sodium selenite on the activity of antioxidant enzymes (superoxide dismutase, glutathione peroxidase) during hepatocarcinogenesis].
Eksp Onkol. 1986;8(4):31-3.
9
Activity of detoxication enzymes in rat hepatoma 27 transplanted in different organs.
Bull Exp Biol Med. 2000 Nov;130(11):1109-12.
10
Oxidant and antioxidant levels in preterm newborns with idiopathic hyperbilirubinaemia.患有特发性高胆红素血症的早产儿体内的氧化剂和抗氧化剂水平
J Paediatr Child Health. 2004 Nov;40(11):633-7. doi: 10.1111/j.1440-1754.2004.00489.x.

引用本文的文献

1
Nanomedicine-based formulations containing ω-3 polyunsaturated fatty acids: potential application in cardiovascular and neoplastic diseases.基于纳米医学的含 ω-3 多不饱和脂肪酸制剂:在心血管和肿瘤疾病中的潜在应用。
Int J Nanomedicine. 2019 Apr 23;14:2809-2828. doi: 10.2147/IJN.S197499. eCollection 2019.
2
Catalase and nonalcoholic fatty liver disease.过氧化氢酶与非酒精性脂肪性肝病。
Pflugers Arch. 2018 Dec;470(12):1721-1737. doi: 10.1007/s00424-018-2195-z. Epub 2018 Aug 17.
3
Interplay Between SIRT-3, Metabolism and Its Tumor Suppressor Role in Hepatocellular Carcinoma.
SIRT-3、代谢及其在肝细胞癌中的肿瘤抑制作用之间的相互作用
Dig Dis Sci. 2017 Aug;62(8):1872-1880. doi: 10.1007/s10620-017-4615-x. Epub 2017 May 19.
4
Meta-analysis of the correlation between selenium and incidence of hepatocellular carcinoma.硒与肝细胞癌发病率相关性的荟萃分析。
Oncotarget. 2016 Nov 22;7(47):77110-77116. doi: 10.18632/oncotarget.12804.
5
Investigation into the distinct subcellular effects of docosahexaenoic acid loaded low-density lipoprotein nanoparticles in normal and malignant murine liver cells.二十二碳六烯酸负载的低密度脂蛋白纳米颗粒在正常和恶性小鼠肝细胞中的不同亚细胞效应研究。
Biochim Biophys Acta. 2016 Nov;1860(11 Pt A):2363-2376. doi: 10.1016/j.bbagen.2016.07.004. Epub 2016 Jul 11.
6
The implications of hyponitroxia in cancer.低亚硝酸盐血症在癌症中的影响。
Transl Oncol. 2014 Apr;7(2):167-73. doi: 10.1016/j.tranon.2014.02.001. Epub 2014 Mar 4.
7
Is SOD1 loss of function involved in amyotrophic lateral sclerosis?SOD1 失活是否与肌萎缩侧索硬化有关?
Brain. 2013 Aug;136(Pt 8):2342-58. doi: 10.1093/brain/awt097. Epub 2013 May 17.
8
A possible predictive marker of progression for hepatocellular carcinoma.一种可能的肝细胞癌进展预测标志物。
Oncol Lett. 2011 Nov;2(6):1247-1251. doi: 10.3892/ol.2011.378. Epub 2011 Aug 9.
9
Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview.肝癌的分子靶点和氧化应激生物标志物:概述。
J Transl Med. 2011 Oct 10;9:171. doi: 10.1186/1479-5876-9-171.
10
Dramatic down-regulation of oxidoreductases in human hepatocellular carcinoma hepG2 cells: proteomics and gene ontology unveiling new frontiers in cancer enzymology.人肝癌HepG2细胞中氧化还原酶的显著下调:蛋白质组学和基因本体论揭示癌症酶学新前沿
Proteome Sci. 2008 Oct 24;6:29. doi: 10.1186/1477-5956-6-29.